List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 26 studies with search of: Keratoconjunctivitis sicca
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Pimecrolimus
2 Completed Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: CF101;   Drug: Placebo
3 Completed A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: voclosporin ophthalmic solution
4 Completed Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome
Intervention: Drug: Cyclosporin A
5 Recruiting Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
Condition: Keratoconjunctivitis Sicca
Interventions: Dietary Supplement: Hydroeye;   Other: Inactive Capsule
6 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
7 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
8 Recruiting Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: rebamipide 2% ophthalmic suspension;   Drug: placebo eye drops
9 Not yet recruiting Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
Conditions: Keratoconjunctivitis Sicca;   Dry Eye
Interventions: Drug: rebamipide 2% ophthalmic suspension;   Drug: placebo eye drops
10 Recruiting Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: AT01;   Drug: AT02;   Drug: AT03;   Drug: AT04
11 Completed Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: Systane Ocular Drops (OTC);   Drug: Placebo - Saline Drops
12 Completed Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome;   Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid;   Scleroderma, Systemic
Intervention: Drug: Ophthalmic Emulsion
13 Completed Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: cyclosporine ophthalmic emulsion 0.05%, artificial tears
14 Active, not recruiting Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
Condition: Keratoconjunctivitis Sicca
Interventions: Procedure: PRK with conjunctival impression cytology before and after surgery;   Procedure: LASIK with conjunctival impression cytology before and after surgery
15 Not yet recruiting Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD);   Drug: sodium hyaluronate 0.18% (VISMED® Multi)
16 Recruiting Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Conditions: Dry Eye Disease;   Keratoconjunctivitis Sicca
Interventions: Drug: Lotemax;   Drug: Restasis
17 Recruiting Effect of B-Cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjögren's Syndrome;   Xerostomia;   Hyposalivation;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
18 Completed Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: INS365 Ophthalmic Solution
19 Completed Tear Film Break-up Time After Instillation of Artificial Tears
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: glycerin;   Drug: polyethylene glycol 400/propylene glycol
20 Recruiting Acupuncture Treatment of Dry Eye
Conditions: Keratoconjunctivitis Sicca;   Xeropthalmia
Interventions: Procedure: Acupuncture;   Procedure: Sham acupuncture

Previous Page Studies Shown (1-20) Next Page (21-26)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services